Active8: a randomized, double-blind, placebo-controlled study of chemotherapy plus cetuximab in combination with TLR8 agonist VTX-2337 in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN)

Saved in:
Bibliographic Details
Published in:J Immunother Cancer
Main Authors: Ferris, Robert L, Cohen, Ezra, Gash, Kelly, Whiting, Sam, Manjarrez, Kristi, Dietsch, Greg, Hershberg, Robert, Bryan, James Kyle
Format: Artigo
Language:Inglês
Published: BioMed Central 2014
Subjects:
Poster Presentation
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4288723/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2051-1426-2-S3-P69
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items